Calculate Invokana lawsuit settlements. Leg amputation, toe amputation, diabetic ketoacidosis claims.
Calculate SettlementJohnson & Johnson
Manufacturer
2x Higher
Amputation Risk
Black Box (2017)
FDA Warning
Active
Litigation
Above or below knee amputation
$400,000
projected value
One or more toes removed
$200,000
projected value
Life-threatening DKA episode
$150,000
projected value
Invokana lawsuits allege that Johnson & Johnson knew about amputation risks but failed to warn patients. In 2017, the FDA added a black box warning after studies showed Invokana doubled the risk of leg and foot amputations.
Invokana (canagliflozin) is an SGLT2 inhibitor diabetes drug. The mechanism may involve reduced blood flow to extremities, increasing infection and gangrene risk in diabetics who already have circulation problems.
Free calculator based on 2026 litigation data.
Start Free Calculator